Variety of approved drugs target PINK1 protein, may aid Parkinson’s
An artificial intelligence (AI)-based algorithm identified more than a dozen U.S.-approved medications that might be repurposed to treat Parkinson’s disease, all based on their ability to increase levels of the PINK1 protein. PINK1 is involved in the health and workings of mitochondria, the cells’ energy production centers, and has…